Webinar - PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology

The First Wave of Immuno-Oncology, presents a view of the most important market developments in immuno-oncology today.

Webinar recording includes:
- An overview of the current immuno-oncology market
- Ongoing developments in the PD-1/PD-L1 therapy space
- Challenges with PD-1/PD-L1 inhibitor development and treatment
- An examination of:
- Non-small cell lung cancer (NSCLC)
- Bladder cancer
- A look at the future of immuno-oncology.

PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology is based on information from Datamonitor Healthcare, part of the Informa Pharma Intelligence suite of tools. Datamonitor Healthcare’s in-depth, interactive research and expert analysis keep you strategically aligned with developments across immuno-oncology, including emerging therapies, companies, drugs, and market trends.

Видео Webinar - PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology канала Pharma intelligence | informa